Interesting, at least in rats an AI made their HDL go up a little while decreasing tot Chol, though they didn't find the increase significant.  
Treatment          Chol, mg/dl         HDL-Chol, mg/dl               Triglycerides, mg/dl
TI                     1,448  ± 46          98  ± 6                             297  ± 34
TI + A               1,276  ± 37          117  ± 6                           267  ± 22
Orch + P            1,677  ± 125        64  ± 4*                           250  ± 26
Orch + T            1,290  ± 54**     64  ± 10*                          247  ± 19
Orch + T + A      1,405  ± 85**     81  ± 11                            300  ± 33
Orch + E2          1,188  ± 152**   89  ± 10**,***                   122  ± 16*,**,***
"In TI mice given the aromatase inhibitor, HDL levels were similar to those in TI animals given vehicle, despite greater lesion formation in the animals receiving the aromatase inhibitor (Table 
(Table2).2) "
Also interesting, in castrated rats with no T, giving them E2 caused them to have no extra aortic lesions.  Implying it's only the lack of E2 that causes a problem and not the Arimidex  itself, only the effect of lowering E2.
		
		
	
	
"The aromatase inhibitor did not accentuate atherogenesis itself as in oophorectomized female LDLR−/−mice, E2 supplementation, when given alone or in combination with the aromatase inhibitor, inhibited atherogenesis to the same extent (L.N., unpublished observations). "
This seems to support AI as being non-toxic while lowering E2 too much is the problem.
Thanks for the study!